• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂治疗在临床实践中的适宜性:门诊患者的前瞻性评估和药物优化的前瞻性评估。

Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.

机构信息

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.

出版信息

Dig Liver Dis. 2020 Aug;52(8):862-868. doi: 10.1016/j.dld.2020.05.005. Epub 2020 Jun 3.

DOI:10.1016/j.dld.2020.05.005
PMID:32505566
Abstract

BACKGROUND

High rates of inappropriate proton pump inhibitor (PPI) prescriptions have been reported in retrospective database analyses. Assessing the appropriateness of long-term PPIs in outpatients, with a proactive approach at drug optimisation may enhance treatment adequacy.

AIMS

To describe the characteristics of outpatients who are on long-term PPIs, to assess the magnitude of inappropriate PPI prescriptions, and to evaluate the rate of drug optimisation following specialist recommendations.

METHODS

Appropriateness of long-term (>8weeks) PPI prescription was prospectively assessed in 249 consecutive patients referred to a Gastroenterology outpatient clinic. We recorded reason for prescription, dose, modality, duration of therapy, and attempts at PPI optimisation.

RESULTS

PPIs were inappropriately prescribed in 96/249 patients (38.6%). Gastro-oesophageal reflux disease (50/143, 35.0%) and prophylaxis of anti-platelet/non-steroidal anti-inflammatory drugs (5/49, 10.2%) were the most common PPI indications and those with the lowest rate of inappropriateness, while the highest rates were observed for treatment of dyspepsia (10/12, 83.3%) and anti-coagulant therapy (21/21, 100%). PPI treatment was optimised in 112 patients (45.0%).

CONCLUSIONS

PPIs are inappropriately used in about 40% of outpatients, reflecting scant attention to guidelines. A proactive approach may improve therapeutic adequacy in approximately half of patients. Educational efforts to guide PPI prescription should be further pursued.

摘要

背景

回顾性数据库分析报告质子泵抑制剂(PPI)的不合理处方率较高。主动优化药物可能会提高治疗的充分性,从而评估门诊患者长期使用 PPI 的适宜性。

目的

描述长期使用 PPI 的门诊患者的特征,评估不合理 PPI 处方的程度,并评估根据专家建议进行药物优化的比例。

方法

前瞻性评估 249 例连续就诊于消化科门诊的患者长期(>8 周)使用 PPI 的情况。我们记录了处方的原因、剂量、方式、治疗持续时间以及 PPI 优化的尝试。

结果

96/249 例(38.6%)患者 PPI 处方不合理。胃食管反流病(50/143,35.0%)和预防抗血小板/非甾体抗炎药(5/49,10.2%)是最常见的 PPI 适应证,也是不合理程度最低的适应证,而治疗消化不良(10/12,83.3%)和抗凝治疗(21/21,100%)的不合理程度最高。112 例(45.0%)患者接受了 PPI 治疗优化。

结论

约 40%的门诊患者不合理使用 PPI,反映出对指南的关注不足。主动的方法可能会改善约一半患者的治疗充分性。应进一步开展指导 PPI 处方的教育工作。

相似文献

1
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.质子泵抑制剂治疗在临床实践中的适宜性:门诊患者的前瞻性评估和药物优化的前瞻性评估。
Dig Liver Dis. 2020 Aug;52(8):862-868. doi: 10.1016/j.dld.2020.05.005. Epub 2020 Jun 3.
2
Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.黎巴嫩门诊环境中用于预防胃肠道出血的质子泵抑制剂的处方:模式、指南遵循情况及风险
Int J Pharm Pract. 2019 Aug;27(4):386-392. doi: 10.1111/ijpp.12537. Epub 2019 Apr 3.
3
Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.质子泵抑制剂的利用与潜在不适当处方分析:来自单中心回顾性研究的见解。
BMJ Open. 2020 Nov 26;10(11):e040473. doi: 10.1136/bmjopen-2020-040473.
4
[Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].[老年急性护理病房中75岁及以上老年人质子泵抑制剂处方的评估]
Therapie. 2017 Dec;72(6):669-675. doi: 10.1016/j.therap.2017.06.003. Epub 2017 Jul 29.
5
Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.B细胞非霍奇金淋巴瘤中是否存在质子泵抑制剂的过度使用?一项基于法国南部比利牛斯地区医疗保险数据库的队列研究。
Fundam Clin Pharmacol. 2019 Jun;33(3):327-338. doi: 10.1111/fcp.12436. Epub 2019 Jan 20.
6
[Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].[专业实践评估对医院质子泵抑制剂处方相关性的影响]
Rev Med Interne. 2018 Aug;39(8):618-626. doi: 10.1016/j.revmed.2018.03.006. Epub 2018 Apr 5.
7
The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.医院环境中口服质子泵抑制剂的不适当处方:一项前瞻性横断面研究。
Dig Dis Sci. 2015 Aug;60(8):2280-6. doi: 10.1007/s10620-015-3642-8. Epub 2015 Apr 4.
8
Appropriate proton pump inhibitors use in elderly outpatients according to recommendations.根据建议在老年门诊患者中合理使用质子泵抑制剂。
Geriatr Psychol Neuropsychiatr Vieil. 2016 Dec 1;14(4):383-388. doi: 10.1684/pnv.2016.0623.
9
Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.大型学术医疗系统中老年患者质子泵抑制剂的低价值处方
J Am Geriatr Soc. 2019 Dec;67(12):2600-2604. doi: 10.1111/jgs.16117. Epub 2019 Sep 5.
10
The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.意大利一家医院质子泵抑制剂的使用情况:聚焦肿瘤患者及非重症监护病房的危重症患者
Int J Clin Pharm. 2015 Dec;37(6):1152-61. doi: 10.1007/s11096-015-0178-0. Epub 2015 Aug 30.

引用本文的文献

1
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia.自身免疫性慢性萎缩性胃炎:长期使用质子泵抑制剂与更严重的萎缩及胃黏膜肠化生之间的关联。
Eur J Gastroenterol Hepatol. 2025 Aug 1;37(8):905-910. doi: 10.1097/MEG.0000000000002989. Epub 2025 Jun 25.
2
Proton Pump Inhibitor Prescription in Nursing Home Residents: Prevalence, Appropriateness, and Associated Factors-A Secondary Data Analysis from Three German Regions and the Impact of Guideline Recommendations.疗养院居民的质子泵抑制剂处方:患病率、合理性及相关因素——来自德国三个地区的二次数据分析及指南建议的影响
Pharmaceuticals (Basel). 2024 Aug 17;17(8):1082. doi: 10.3390/ph17081082.
3
May an aspirin a day truly take hepatocellular carcinoma away?每日一片阿司匹林真的能远离肝细胞癌吗?
Ann Transl Med. 2023 Mar 15;11(5):225. doi: 10.21037/atm-22-6434. Epub 2023 Jan 16.
4
Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria.尼日利亚一家三级教学医院质子泵抑制剂使用情况的评估。
Med Access Point Care. 2021 Dec 5;5:23992026211062729. doi: 10.1177/23992026211062729. eCollection 2021 Jan-Dec.
5
Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.质子泵抑制剂管理委员会的多方面干预对门诊和急诊科酸抑制剂处方模式的影响。
BMC Health Serv Res. 2022 Mar 29;22(1):417. doi: 10.1186/s12913-022-07820-x.
6
Low-value pharmaceutical care among Dutch GPs: a retrospective cohort study.荷兰全科医生中低价值药物治疗:一项回顾性队列研究。
Br J Gen Pract. 2022 Apr 28;72(718):e369-e377. doi: 10.3399/BJGP.2021.0625. Print 2022 May.
7
Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.质子泵抑制剂的利用与潜在不适当处方分析:来自单中心回顾性研究的见解。
BMJ Open. 2020 Nov 26;10(11):e040473. doi: 10.1136/bmjopen-2020-040473.